“…Because of continuous anatomical and biochemical changes during brain development, the use of different drug doses by various studies, different drug administration times, and different postnatal ages of testing, there is greater variability for in utero studies than for those using mature animals. For example, several studies reported increased open field behavior, increased active avoidance, and decreased Lashley I11 maze performance (Martin and Martin, 1981;Nasello and Ramirez, 1978;Seliger, 1973) when amphetamine was administered throughout the entire gestation period, drug doses were in a moderate range (0.5-5 mgl kg), and rats were tested after weaning. However, when amphetamine was administered for a restricted period during gestation or when preweanlings were tested, motor activity was either elevated (Hitzemann et al, 1976), not different (Adams et al, 1982;Middaugh et al, 1974;Monder, 1981), or reduced (Bell et al, 1965;Clark et al, 1970) as compared to controls.…”